Thymol Improves Brain Functional Outcomes after Cerebral Ischemia-Reperfusion Injury by Regulating p38 MAPK Associated Apoptosis Signalling Pathway
1, 2, 3
- 1Department of Pharmacology, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati (Affiliated to JNTU), Anantapur, Andhra Pradesh, INDIA.
- 2Department of Pharmaceutics, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati (Affiliated to JNTU), Anantapur, Andhra Pradesh, INDIA.
- 3Department of Pharmacology, Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visva Vidyalayam, Tirupati, Andhra Pradesh, INDIA.
CORRESPONDENCE
Dr. Hima Saila MukkudiahgariDepartment of Pharmacology, Sri Padmavathi
School of Pharmacy, Tiruchanoor, Tirupati (Affiliated to JNTU), Anantapur, Andhra Pradesh, INDIA.
Received: 19-04-2024; Revised: 10-08-2024; Accepted: 13-02-2025.
Volume 59, Issue 2 · pp. 790-799 · 2025 · DOI: 10.5530/ijper.20257027
ABSTRACT
Background: Thymol, a monoterpene phenolic compound and an essential oil extracted from Tachyspermum ammi (ajwain) has been shown to possess multiple therapeutic potentials as anti-inflammatory, antioxidant, antihyperlipidemic, antiapoptotic, antitumor agent against neurological, cardiovascular, gastrointestinal and malignant diseases.Objectives: The current investigation aimed to determine whether thymol could protect rats from cerebral ischemia reperfusion injury by preventing Bilateral Common Carotid Artery Occlusion (BCCAO).Materials and Methods: After 14 days of pretreatment with thymol at the doses of 50 mg/kg, p.o and 100 mg/kg, p.o. respectively, Albino Wistar rats (200-250 g) were subjected to BCCAO for 1 hr followed by 22 hr reperfusion (I/R). The levels of protein carbonyl content, Myeloperoxidase (MPO) were measured in brain tissue homogenate. Utilising western blotting, the expression levels of TNF-α, Interleukin 10 (IL-10) anti-inflammatory cytokines, pro-apoptotic mediators Bax and Caspase 3 and anti-apoptotic mediator Bcl-2 were assessed. Results and Discussion: Reduction in levels of protein carbonyl content and Myeloperoxidase (MPO) was observed in thymol groups. Thymol pretreated rats showed significant (p<0.01) downregulation in the expressions of TNF-α and inhibited phosphorylation of p38 MAPK. In parallel, the expressions of IL-10 were upregulated significantly (p<0.01). Thymol exerted anti-apoptotic effect as reflected by decreased expression of the key downstream executioner caspase-3 and Bax, which is probably mediated by significant upregulation of expression of Bcl-2.Conclusion: Thymol is endowed with neuroprotection against global cerebral ischemia reperfusion injury which may be probably mediated by attenuation of inflammatory and apoptotic mechanism via p38 MAPK signaling pathway.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Mukkudiahgari, H. S., Kudamala, R. R., & Thakur, S. (2025). Thymol Improves Brain Functional Outcomes after Cerebral Ischemia-Reperfusion Injury by Regulating p38 MAPK Associated Apoptosis Signalling Pathway. Indian Journal of Pharmaceutical Education and Research, 59(2), 790-799. https://doi.org/10.5530/ijper.20257027
Copyright and licence
© 2025 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0